Ovid Therapeutics, Inc. (OVID)
2.375
-0.10
(-3.85%)
USD |
NASDAQ |
Oct 22, 16:00
2.375
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Price : 2.375 for Oct. 22, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | 2.37 | 2.65 | 2.345 | 2.47 | 5.006M |
| Oct 20, 2026 | 2.19 | 2.46 | 2.175 | 2.36 | 3.669M |
| Oct 19, 2026 | 2.18 | 2.225 | 2.14 | 2.17 | 1.641M |
| Oct 16, 2026 | 2.26 | 2.30 | 2.11 | 2.15 | 1.325M |
| Oct 15, 2026 | 2.21 | 2.31 | 2.19 | 2.26 | 1.333M |
| Oct 14, 2026 | 2.18 | 2.255 | 2.09 | 2.19 | 1.642M |
| Oct 13, 2026 | 2.41 | 2.415 | 2.18 | 2.19 | 1.643M |
| Oct 12, 2026 | 2.45 | 2.493 | 2.394 | 2.41 | 876042.0 |
| Oct 09, 2026 | 2.37 | 2.475 | 2.33 | 2.46 | 1.407M |
| Oct 08, 2026 | 2.32 | 2.36 | 2.29 | 2.34 | 1.649M |
| Oct 07, 2026 | 2.36 | 2.46 | 2.34 | 2.36 | 1.004M |
| Oct 06, 2026 | 2.42 | 2.44 | 2.27 | 2.37 | 1.735M |
| Oct 05, 2026 | 2.38 | 2.47 | 2.29 | 2.34 | 1.200M |
| Oct 02, 2026 | 2.47 | 2.48 | 2.33 | 2.38 | 2.174M |
| Oct 01, 2026 | 2.49 | 2.53 | 2.42 | 2.43 | 1.349M |
| Sep 30, 2026 | 2.54 | 2.605 | 2.48 | 2.49 | 1.443M |
| Sep 29, 2026 | 2.47 | 2.54 | 2.42 | 2.54 | 1.164M |
| Sep 28, 2026 | 2.40 | 2.49 | 2.35 | 2.46 | 1.193M |
| Sep 25, 2026 | 2.49 | 2.51 | 2.40 | 2.40 | 1.365M |
| Sep 24, 2026 | 2.54 | 2.54 | 2.405 | 2.495 | 1.528M |
| Sep 23, 2026 | 2.75 | 2.75 | 2.44 | 2.57 | 2.635M |
| Sep 22, 2026 | 2.76 | 2.845 | 2.714 | 2.76 | 3.744M |
| Sep 21, 2026 | 2.73 | 2.76 | 2.65 | 2.71 | 1.184M |
| Sep 18, 2026 | 2.68 | 2.73 | 2.63 | 2.69 | 5.899M |
| Sep 17, 2026 | 2.73 | 2.77 | 2.66 | 2.70 | 1.986M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.30 |
| Alnylam Pharmaceuticals, Inc. | 227.30 |
| Anika Therapeutics, Inc. | 21.02 |
| Savara, Inc. | 4.54 |
| Vericel Corp. | 42.98 |
Price Related Metrics
| PS Ratio | 182.44 |
| Price to Book Value | 2.091 |
| Earnings Yield | -10.67% |
| Market Cap | 438.79M |